RT Journal Article
SR Electronic
T1 Genetic surveillance in the Greater Mekong Subregion and South Asia to support malaria control and elimination
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.23.20159624
DO 10.1101/2020.07.23.20159624
A1 Christopher G Jacob
A1 Nguyen Thuy-Nhien
A1 Mayfong Mayxay
A1 Richard J Maude
A1 Huynh Hong Quang
A1 Bouasy Hongvanthong
A1 Viengxay Vanisaveth
A1 Thang Ngo Duc
A1 Huy Rekol
A1 Rob W van der Pluijm
A1 Lorenz Von Seidlein
A1 Rick M Fairhurst
A1 Francois H Nosten
A1 Md Amir Hossain
A1 Naomi Park
A1 Scott Goodwin
A1 Pascal Ringwald
A1 Keobouphaphone Chindavongsa
A1 Paul N Newton
A1 Elizabeth A Ashley
A1 Sonexay Phalivong
A1 Rapeephan R Maude
A1 Rithea Leang
A1 Cheah Huch
A1 Le Thanh Dong
A1 Kim-Tuyen Nguyen
A1 Tran Minh Nhat
A1 Tran Tinh Hien
A1 Hoa Nguyen
A1 Nicole Zdrojewski
A1 Sara E Canavati
A1 Abdullah A Sayeed
A1 Didar Uddin
A1 Caroline Buckee
A1 Caterina I Fanello
A1 Marie Onyamboko
A1 Thomas Peto
A1 Rupam Tripura
A1 Chanaki Amaratunga
A1 Aung Myint Thu
A1 Gilles Delmas
A1 Jordi Landier
A1 Nguyen Hoang Chau
A1 Dysoley Lek
A1 Seila Suon
A1 James J Callery
A1 Podjanee Jittamala
A1 Borimas Hanboonkunupakarn
A1 Sasithon Pukrittayakamee
A1 Aung Pyae Phyo
A1 Frank Smithuis
A1 Khin Lin
A1 Myo Thant
A1 Tin Maung Hlaing
A1 Parthasarathi Satpathi
A1 Sanghamitra Satpathi
A1 Prativa K Behera
A1 Amar Tripura
A1 Subrata Baidya
A1 Neena Valecha
A1 Anupkumar R Anvikar
A1 Akhter ul Islam
A1 Abul Faiz
A1 Chanon Kunasol
A1 Eleanor Drury
A1 Mihir Kekre
A1 Mozam Ali
A1 Katie Love
A1 Shavanthi Rajatileka
A1 Anna E Jeffreys
A1 Kate Rowlands
A1 Christina S Hubbart
A1 Mehul Dhorda
A1 Ranitha Vongpromek
A1 Namfon Kotanan
A1 Phrutsamon Wongnak
A1 Jacob Almagro Garcia
A1 Richard D Pearson
A1 Cristina V Ariani
A1 Thanat Chookajorn
A1 Cinzia Malangone
A1 T Nguyen
A1 Jim Stalker
A1 Ben Jeffery
A1 Jonathan Keatley
A1 Kimberly Johnson
A1 Dawn Muddyman
A1 Xin Hui S Chan
A1 John Sillitoe
A1 Roberto Amato
A1 Victoria Simpson
A1 Sonia Gonçalves
A1 Kirk Rockett
A1 Nicholas P Day
A1 Arjen M Dondorp
A1 Dominic P Kwiatkowski
A1 Olivo Miotto
YR 2020
UL http://medrxiv.org/content/early/2020/10/03/2020.07.23.20159624.abstract
AB The use of parasite genetic data by National Malaria Control Programmes (NMCPs) is currently limited, and typically focused on specific genetic features or a small number of study sites. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS). By integrating simple sample collection procedures in the routine operations of public health facilities, GenRe-Mekong enables NMCPs to conduct large-scale surveillance project in endemic regions. Samples are processed by the SpotMalaria platform, which uses high-throughput technologies to produce a broad set of genotypes, including most known drug resistance markers, species markers and a genomic barcode. Through the application of heuristics based on published evidence, GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions that are used to map prevalence of resistance to multiple drugs. To date, GenRe-Mekong has worked with NMCPs in five countries, and with several large-scale research projects, processing 9,623 samples from clinical cases. The monitoring of resistance markers has been especially valuable for NMCPs tracking the recent rapid spread of DHA-piperaquine resistant parasites across the region. In Vietnam and Laos, data from GenRe-Mekong have provided novel knowledge about the spread of these resistant strains in provinces previously thought to be unaffected. GenRe-Mekong facilitates data sharing by aggregating at regional level results from different countries, providing cross-border views of the spread of resistant strains.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBill & Melinda Gates Foundation, Wellcome Trust, UK Medical Research Council, UK Department for International Development, NIAIDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Oxford Tropical Research Ethics Committee, Oxford, UK; Ethical Committee, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Ministry of Health National Ethics Committee For Health Research, Laos; Ethics Committee, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; National Ethics Committee for Health Research, Ministry of Health, Phnom Penh, Cambodia; Ethics Review Committee on medical research involving human beings from Myanmar, Ministry of Health and Sports, Department of Medical Research (Lower Myanmar); Bangladesh Medical Research Council Ethical Committee; Comite d'Ethique, Ecole de Sante Publique, Universite de Kinshasa, Ministere de l'Enseignement Superieur, Universitaire et Recherche Scientifique, D. R. Congo; Harvard University Human Research Protection Program;All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll genotyping data and metadata is available from the manuscript's resource page. https://www.malariagen.net/resource/29